Developer docs
API playgroundTry for free, no card

Search company profiles

Tosoh Bioscience, Inc.

Full company profile

uuid005hp7w

Namestring
Tosoh Bioscience, Inc.
Legal namestring
Tosoh Bioscience, Inc.
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Tosoh Bioscience, Inc. is the US-based clinical diagnostics subsidiary of Tosoh Corporation, a Japanese conglomerate listed on the Tokyo Stock Exchange under ticker 4045. Founded in 1989 and headquartered in Grove City, Ohio with 132 employees, the company develops, manufactures, and distributes in-vitro diagnostic instruments and reagents to clinical laboratories across multiple specialties, with primary emphasis on diabetes testing via hemoglobin A1c measurement and secondary application in reproductive endocrinology, oncology, thyroid, cardiac, renal, metabolic, anemia, and veterinary diagnostics.

The product platform is organized around two core technology pillars. The first is HPLC (high-performance liquid chromatography) for HbA1c analysis, embodied in the HLC-723GR01 (FDA 510(k) cleared October 2025) and HLC-723G8 analyzers, which separate and quantify hemoglobin variants for diabetes diagnosis and monitoring. The second is Fluorescent Enzyme Immunoassay (FEIA), delivered through the AIA-2000 ST, AIA-900, and AIA-360 analyzers that use Tosoh's proprietary AIA-PACK dry-reagent test cups and ST biotin-free immunoassay chemistry to mitigate biotin interference. The portfolio is supported by the 501RP+ reporting middleware for data connectivity and a native integration with Sysmex laboratory automation lines that embeds the G8 into track-based high-volume workflows.

Commercially, Tosoh Bioscience operates a direct enterprise field-sales motion targeting clinical laboratories and specialty healthcare providers in the United States, complemented by event-driven demand generation at industry conferences such as ASRM 2025, content marketing, webinars, and the "Tosoh Ink" newsletter. Revenue is generated through three streams: capital-equipment sales of HPLC and immunoassay analyzers, recurring sales of proprietary AIA-PACK reagent test cups and assay consumables tied to the installed instrument base, and technical support and service contracts. Pricing is quote-based and not publicly disclosed. The US subsidiary operates as one node in Tosoh Corporation's broader bioscience footprint that also spans Europe, China, India, and Asia-Pacific.

Short descriptiontext

Tosoh Bioscience, Inc. is the US clinical diagnostics subsidiary of Japanese conglomerate Tosoh Corporation, selling HPLC A1c analyzers (GR01, G8) and immunoassay systems (AIA-2000/900/360) plus proprietary AIA-PACK reagent consumables to clinical laboratories in diabetes, fertility, oncology, and general chemistry segments.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersGrove City, United States
HQ citystring
Grove City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical diagnostic analyzers, immunoassay testing systems, HPLC A1c testing, diagnostic reagent consumables, clinical laboratory equipment
Industry2 codes
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAALAH
Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Clinical Diagnostic Instruments
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Diagnostic Analyzers
TypeHardware Sales
Description

Sale of clinical diagnostic instruments including HPLC A1c analyzers (GR01, G8) and immunoassay analyzers (AIA-2000, AIA-900, AIA-360). These are capital equipment purchases for clinical laboratories.

tosohbioscience.com
2Reagent and Test Consumables
TypeSubscription Recurring
Description

Recurring revenue from sale of proprietary test reagents, AIA-PACK test cups, and assay reagents used in Tosoh analyzers. Customers require ongoing reagent supply for continuous testing operations.

tosohbioscience.com
3Technical Support and Service
TypeProfessional Services
Description

Technical support and customer service for instrument maintenance, calibration, and troubleshooting. Implied through dedicated support pages and documentation services.

tosohbioscience.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Tosoh Bioscience manufactures, sells, and services clinical diagnostic analyzers and proprietary reagents built on two core technology platforms: HPLC-based HbA1c testing systems (GR01, G8) and automated immunoassay analyzers (AIA-2000 ST, AIA-900 9 Tray Sorter, AIA-360) supported by AIA-PACK dry reagent test cups. The portfolio addresses diabetes, fertility/reproductive medicine, oncology, thyroid, cardiac, kidney, metabolic, anemia, and veterinary testing for clinical laboratories. Revenue combines capital equipment sales, recurring reagent consumables, and ongoing technical service and support.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • GR01 HbA1c Testing Analyzer provides fast, accurate results with FDA 510(k) clearance
Product overview1 text field

Tosoh Bioscience provides a comprehensive portfolio of clinical diagnostic solutions organized around two core technology platforms: HPLC A1c systems (GR01, G8) and automated immunoassay analyzers (AIA-2000 ST, AIA-900, AIA-360). These instruments are supported by AIA-PACK dry reagent technology and the 501RP+ reporting middleware. The company serves diverse clinical specialties including diabetes, reproductive/fertility, tumor markers, thyroid, anemia, cardiac, kidney, metabolic, and veterinary diagnostics. Tosoh's analyzers are designed for laboratories of varying throughput needs, from compact systems for smaller labs to high-volume integrated automation solutions.

Product and service7 records
1GR01 (HLC-723GR01) HbA1c Analyzer
CategoryClinical Diagnostic Instruments — HPLC A1c Analyzers
Description

High-performance HPLC A1c analyzer for hemoglobin A1c testing in diabetes diagnosis and management; FDA 510(k) cleared; designed for clinical laboratories requiring accurate separation and measurement of hemoglobin variants.

2G8 (HLC-723G8) HPLC A1c Analyzer
CategoryClinical Diagnostic Instruments — HPLC A1c Analyzers
Description

HPLC A1c analyzer designed for high-volume clinical laboratory settings, with automated workflow capabilities including Sysmex automation integration for HbA1c testing at scale.

3AIA-2000 ST Immunoassay Analyzer
CategoryClinical Diagnostic Instruments — Immunoassay Analyzers
Description

Automated immunoassay analyzer utilizing AIA-PACK test cup reagent technology for clinical diagnostic testing across multiple specialty areas, including tumor markers, Cystatin C, thyroid, cardiac, and metabolic panels.

4AIA-900 9 Tray Sorter Immunoassay Analyzer
CategoryClinical Diagnostic Instruments — Immunoassay Analyzers
Description

High-throughput immunoassay analyzer with automated sample handling and 9-tray sorter capability, designed for fertility and other specialty clinical testing applications.

5AIA-360 Immunoassay Analyzer
CategoryClinical Diagnostic Instruments — Immunoassay Analyzers
Description

Compact immunoassay analyzer designed for mid-to-low volume laboratories, employing proprietary AIA-PACK dry reagent technology across the Tosoh specialty test menu.

6AIA-PACK Test Cup Reagent Consumables
CategoryDiagnostic Reagents and Consumables
Description

Proprietary dry reagent test cups sold as consumables for use in AIA immunoassay analyzers, featuring fast process times, extended shelf life, and biotin-free immunoassay designs to mitigate biotin interference in test results.

7501RP+ Reporting Middleware
CategoryLaboratory Connectivity and Reporting Software
Description

Reporting middleware solution that enhances data management and connectivity for Tosoh diagnostic analyzers, enabling improved data reporting and integration in clinical laboratory workflows.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Sysmex
Strategic tierCoreTypeTechnology or Integration
Description

Tosoh Bioscience has developed integration between G8 HPLC A1c analyzer and Sysmex automation systems, enabling automated workflow solutions for clinical laboratories. The partnership combines Tosoh's HPLC A1c technology with Sysmex's laboratory automation expertise.

tosohbioscience.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Bio-Rad Laboratories
TypeDirect peer
Description

Bio-Rad manufactures clinical diagnostics instruments and reagents, including diabetes/HbA1c testing systems and immunoassay platforms, directly overlapping with Tosoh's HPLC A1c and immunoassay analyzer offerings.

2Trinity Biotech
TypeDirect peer
Description

Trinity Biotech is a clinical diagnostics company with a strong HbA1c (boronate affinity HPLC) product line and immunoassay offerings, directly competing with Tosoh's HPLC A1c analyzer franchise.

3Roche Diagnostics
TypeBroad incumbent
Description

Roche Diagnostics is a global IVD leader with cobas integrated chemistry/immunoassay platforms and HbA1c assays, competing broadly with Tosoh's analyzer and reagent offerings across hospital and reference labs.

4Abbott Diagnostics
TypeBroad incumbent
Description

Abbott offers the Architect/Alinity clinical chemistry and immunoassay platforms along with diabetes diagnostics, representing a major incumbent competitor to Tosoh's clinical diagnostic systems.

5Siemens Healthineers
TypeBroad incumbent
Description

Siemens Healthineers offers the Atellica and ADVIA Centaur clinical chemistry/immunoassay platforms that compete with Tosoh's AIA immunoassay analyzers in mid- and high-volume hospital labs.

6Beckman Coulter Diagnostics
TypeBroad incumbent
Description

Beckman Coulter provides DxI and Access immunoassay systems plus clinical chemistry analyzers, competing with Tosoh's AIA immunoassay product line in routine clinical laboratories.

7Sebia
TypeEmerging player
Description

Sebia specializes in electrophoresis and HbA1c (capillary electrophoresis) clinical diagnostics, offering an alternative platform technology to Tosoh's HPLC A1c analyzers in specialty and reference labs.

8Ortho Clinical Diagnostics
TypeBroad incumbent
Description

Ortho Clinical Diagnostics (now part of QuidelOrtho) provides Vitros clinical chemistry and immunoassay systems, competing with Tosoh's AIA platform in hospital and blood bank laboratory settings.

9Agilent Technologies
TypeBroad incumbent
Description

Agilent is a major manufacturer of HPLC instruments and consumables used in clinical and research laboratories, broadly comparable to Tosoh's HPLC A1c technology platform.

10Sysmex Corporation
TypeOthers
Description

Sysmex is Tosoh's automation integration partner and a global leader in hematology and clinical lab automation, providing enabling instrumentation to which Tosoh's G8 analyzer connects via mutual automation partnership.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tosoh Bioscience, Inc.

Clinical Diagnostic Instrumentstosohbioscience.us

Tosoh Bioscience, Inc. is the US clinical diagnostics subsidiary of Japanese conglomerate Tosoh Corporation, selling HPLC A1c analyzers (GR01, G8) and immunoassay systems (AIA-2000/900/360) plus proprietary AIA-PACK reagent consumables to clinical laboratories in diabetes, fertility, oncology, and general chemistry segments.

What Tosoh Bioscience, Inc. does

Tosoh Bioscience, Inc. is the US-based clinical diagnostics subsidiary of Tosoh Corporation, a Japanese conglomerate listed on the Tokyo Stock Exchange under ticker 4045. Founded in 1989 and headquartered in Grove City, Ohio with 132 employees, the company develops, manufactures, and distributes in-vitro diagnostic instruments and reagents to clinical laboratories across multiple specialties, with primary emphasis on diabetes testing via hemoglobin A1c measurement and secondary application in reproductive endocrinology, oncology, thyroid, cardiac, renal, metabolic, anemia, and veterinary diagnostics.

The product platform is organized around two core technology pillars. The first is HPLC (high-performance liquid chromatography) for HbA1c analysis, embodied in the HLC-723GR01 (FDA 510(k) cleared October 2025) and HLC-723G8 analyzers, which separate and quantify hemoglobin variants for diabetes diagnosis and monitoring. The second is Fluorescent Enzyme Immunoassay (FEIA), delivered through the AIA-2000 ST, AIA-900, and AIA-360 analyzers that use Tosoh's proprietary AIA-PACK dry-reagent test cups and ST biotin-free immunoassay chemistry to mitigate biotin interference. The portfolio is supported by the 501RP+ reporting middleware for data connectivity and a native integration with Sysmex laboratory automation lines that embeds the G8 into track-based high-volume workflows.

Commercially, Tosoh Bioscience operates a direct enterprise field-sales motion targeting clinical laboratories and specialty healthcare providers in the United States, complemented by event-driven demand generation at industry conferences such as ASRM 2025, content marketing, webinars, and the "Tosoh Ink" newsletter. Revenue is generated through three streams: capital-equipment sales of HPLC and immunoassay analyzers, recurring sales of proprietary AIA-PACK reagent test cups and assay consumables tied to the installed instrument base, and technical support and service contracts. Pricing is quote-based and not publicly disclosed. The US subsidiary operates as one node in Tosoh Corporation's broader bioscience footprint that also spans Europe, China, India, and Asia-Pacific.

Tosoh Bioscience, Inc. firmographics

Firmographics
Name
Tosoh Bioscience, Inc.
Legal name
Tosoh Bioscience, Inc.
Website
https://tosohbioscience.us
Company type
Private
Operating status
Operating
Headcount range
101–250 employees
Short description
Tosoh Bioscience, Inc. is the US clinical diagnostics subsidiary of Japanese conglomerate Tosoh Corporation, selling HPLC A1c analyzers (GR01, G8) and immunoassay systems (AIA-2000/900/360) plus proprietary AIA-PACK reagent consumables to clinical laboratories in diabetes, fertility, oncology, and general chemistry segments.
Ownership category
akta.pro rank

Tosoh Bioscience, Inc. industry classification

Industry
Product category
Clinical Diagnostic Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAALAH
Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing)

Keywords

  • Clinical diagnostic analyzers
  • Immunoassay testing systems
  • HPLC A1c testing
  • Diagnostic reagent consumables
  • Clinical laboratory equipment

Where Tosoh Bioscience, Inc. is headquartered

Location

Headquarters

HQ city
Grove City
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Tosoh Bioscience, Inc. business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Diagnostic Analyzers: Sale of clinical diagnostic instruments including HPLC A1c analyzers (GR01, G8) and immunoassay analyzers (AIA-2000, AIA-900, AIA-360). These are capital equipment purchases for clinical laboratories.
  2. Reagent and Test Consumables: Recurring revenue from sale of proprietary test reagents, AIA-PACK test cups, and assay reagents used in Tosoh analyzers. Customers require ongoing reagent supply for continuous testing operations.
  3. Technical Support and Service: Technical support and customer service for instrument maintenance, calibration, and troubleshooting. Implied through dedicated support pages and documentation services.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels7 records

Tosoh Bioscience, Inc. product offering

Product offering

Core offering

Tosoh Bioscience manufactures, sells, and services clinical diagnostic analyzers and proprietary reagents built on two core technology platforms: HPLC-based HbA1c testing systems (GR01, G8) and automated immunoassay analyzers (AIA-2000 ST, AIA-900 9 Tray Sorter, AIA-360) supported by AIA-PACK dry reagent test cups. The portfolio addresses diabetes, fertility/reproductive medicine, oncology, thyroid, cardiac, kidney, metabolic, anemia, and veterinary testing for clinical laboratories. Revenue combines capital equipment sales, recurring reagent consumables, and ongoing technical service and support.

Product overview

Tosoh Bioscience provides a comprehensive portfolio of clinical diagnostic solutions organized around two core technology platforms: HPLC A1c systems (GR01, G8) and automated immunoassay analyzers (AIA-2000 ST, AIA-900, AIA-360). These instruments are supported by AIA-PACK dry reagent technology and the 501RP+ reporting middleware. The company serves diverse clinical specialties including diabetes, reproductive/fertility, tumor markers, thyroid, anemia, cardiac, kidney, metabolic, and veterinary diagnostics. Tosoh's analyzers are designed for laboratories of varying throughput needs, from compact systems for smaller labs to high-volume integrated automation solutions.

Differentiator

Problem solved

Functional benefit

Products and services

  • GR01 (HLC-723GR01) HbA1c Analyzer High-performance HPLC A1c analyzer for hemoglobin A1c testing in diabetes diagnosis and management; FDA 510(k) cleared; designed for clinical laboratories requiring accurate separation and measurement of hemoglobin variants.
  • G8 (HLC-723G8) HPLC A1c Analyzer HPLC A1c analyzer designed for high-volume clinical laboratory settings, with automated workflow capabilities including Sysmex automation integration for HbA1c testing at scale.
  • AIA-2000 ST Immunoassay Analyzer Automated immunoassay analyzer utilizing AIA-PACK test cup reagent technology for clinical diagnostic testing across multiple specialty areas, including tumor markers, Cystatin C, thyroid, cardiac, and metabolic panels.
  • AIA-900 9 Tray Sorter Immunoassay Analyzer High-throughput immunoassay analyzer with automated sample handling and 9-tray sorter capability, designed for fertility and other specialty clinical testing applications.
  • AIA-360 Immunoassay Analyzer Compact immunoassay analyzer designed for mid-to-low volume laboratories, employing proprietary AIA-PACK dry reagent technology across the Tosoh specialty test menu.
  • AIA-PACK Test Cup Reagent Consumables Proprietary dry reagent test cups sold as consumables for use in AIA immunoassay analyzers, featuring fast process times, extended shelf life, and biotin-free immunoassay designs to mitigate biotin interference in test results.
  • 501RP+ Reporting Middleware Reporting middleware solution that enhances data management and connectivity for Tosoh diagnostic analyzers, enabling improved data reporting and integration in clinical laboratory workflows.

Quantifiable outcome

  • GR01 HbA1c Testing Analyzer provides fast, accurate results with FDA 510(k) clearance

Companies that use Tosoh Bioscience, Inc.

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles2 records

Tosoh Bioscience, Inc. technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Tosoh Bioscience, Inc. partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • SysmexcoreTechnology or IntegrationTosoh Bioscience has developed integration between G8 HPLC A1c analyzer and Sysmex automation systems, enabling automated workflow solutions for clinical laboratories. The partnership combines Tosoh's HPLC A1c technology with Sysmex's laboratory automation expertise.

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

Tosoh Bioscience, Inc. competitors and assessment

Company assessment

Direct peers

  • Bio-Rad Laboratories: Bio-Rad manufactures clinical diagnostics instruments and reagents, including diabetes/HbA1c testing systems and immunoassay platforms, directly overlapping with Tosoh's HPLC A1c and immunoassay analyzer offerings.
  • Trinity Biotech: Trinity Biotech is a clinical diagnostics company with a strong HbA1c (boronate affinity HPLC) product line and immunoassay offerings, directly competing with Tosoh's HPLC A1c analyzer franchise.

Broad incumbents

  • Roche Diagnostics: Roche Diagnostics is a global IVD leader with cobas integrated chemistry/immunoassay platforms and HbA1c assays, competing broadly with Tosoh's analyzer and reagent offerings across hospital and reference labs.
  • Abbott Diagnostics: Abbott offers the Architect/Alinity clinical chemistry and immunoassay platforms along with diabetes diagnostics, representing a major incumbent competitor to Tosoh's clinical diagnostic systems.
  • Siemens Healthineers: Siemens Healthineers offers the Atellica and ADVIA Centaur clinical chemistry/immunoassay platforms that compete with Tosoh's AIA immunoassay analyzers in mid- and high-volume hospital labs.
  • Beckman Coulter Diagnostics: Beckman Coulter provides DxI and Access immunoassay systems plus clinical chemistry analyzers, competing with Tosoh's AIA immunoassay product line in routine clinical laboratories.
  • Ortho Clinical Diagnostics: Ortho Clinical Diagnostics (now part of QuidelOrtho) provides Vitros clinical chemistry and immunoassay systems, competing with Tosoh's AIA platform in hospital and blood bank laboratory settings.
  • Agilent Technologies: Agilent is a major manufacturer of HPLC instruments and consumables used in clinical and research laboratories, broadly comparable to Tosoh's HPLC A1c technology platform.

Emerging players

  • Sebia: Sebia specializes in electrophoresis and HbA1c (capillary electrophoresis) clinical diagnostics, offering an alternative platform technology to Tosoh's HPLC A1c analyzers in specialty and reference labs.

Others

  • Sysmex Corporation: Sysmex is Tosoh's automation integration partner and a global leader in hematology and clinical lab automation, providing enabling instrumentation to which Tosoh's G8 analyzer connects via mutual automation partnership.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks4 records

Key highlights6 records

Customer concentration

Tosoh Bioscience, Inc. compliance and trust

Trust signal

Compliance1 record

Tosoh Bioscience, Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tosoh Bioscience, Inc. leadership team

Management profile

Number of profiles

Profiles1 record

Tosoh Bioscience, Inc. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tosoh Bioscience, Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tosoh Bioscience, Inc.

What does Tosoh Bioscience, Inc. do?

Tosoh Bioscience manufactures, sells, and services clinical diagnostic analyzers and proprietary reagents built on two core technology platforms: HPLC-based HbA1c testing systems (GR01, G8) and automated immunoassay analyzers (AIA-2000 ST, AIA-900 9 Tray Sorter, AIA-360) supported by AIA-PACK dry reagent test cups. The portfolio addresses diabetes, fertility/reproductive medicine, oncology, thyroid, cardiac, kidney, metabolic, anemia, and veterinary testing for clinical laboratories. Revenue combines capital equipment sales, recurring reagent consumables, and ongoing technical service and support.

Is Tosoh Bioscience, Inc. a public or private company?

Tosoh Bioscience, Inc. is a private company. It is classified as corporate owned and is currently operating.

When was Tosoh Bioscience, Inc. founded?

Tosoh Bioscience, Inc. was founded in -1. It employs 101 to 250 people.

Where is Tosoh Bioscience, Inc. based?

Tosoh Bioscience, Inc. is headquartered in Grove City, United States, in the North America region.

How does Tosoh Bioscience, Inc. make money?

Three revenue lines are on record. Clinical Diagnostic Analyzers are the primary driver. The others are reagent and Test Consumables and technical Support and Service.

Who are Tosoh Bioscience, Inc.'s main competitors?

Direct peers on record are Bio-Rad Laboratories and Trinity Biotech. Broad incumbents are Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Beckman Coulter Diagnostics, Ortho Clinical Diagnostics and Agilent Technologies. Sebia is listed as an emerging player. Sysmex Corporation is listed as an others.

Does Tosoh Bioscience, Inc. have an API?

No public API is recorded for Tosoh Bioscience, Inc..

What industry is Tosoh Bioscience, Inc. in?

Tosoh Bioscience, Inc.'s product category is Clinical Diagnostic Instruments. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAALAH, Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals